BIOMAT Database Logo BIOMAT Database Logo

[The antiarrhythmic activity of the polymeric forms of quinidine, trimecaine, etatsizin, propranolol and verapamil]. 1993

G I Sidorenko, and A V Gurin, and M G Koliadko, and T L Iurkshtovich, and V L Nedorezov

The antiarrhythmic activity and acute toxicity of polymeric formulations of quinidine, trimecaine, ethacizine, propranolol, verapamil which had been immobilized on a cellulose carrier (monocarboxylcellulose) and low molecular analogues were studied in various experimental animals (rats, mice, dogs). The polymeric formulations of trimecaine and verapamil were found to have a higher antiarrhythmic activity in different arrhythmia models than trimecaine and verapamil. The toxicity of all new compounds was no more than the values of conventional antiarrhythmic drugs.

UI MeSH Term Description Entries
D008297 Male Males
D010640 Phenothiazines Compounds containing dibenzo-1,4-thiazine. Some of them are neuroactive.
D011108 Polymers Compounds formed by the joining of smaller, usually repeating, units linked by covalent bonds. These compounds often form large macromolecules (e.g., BIOPOLYMERS; PLASTICS). Polymer
D011433 Propranolol A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs. Dexpropranolol,AY-20694,Anaprilin,Anapriline,Avlocardyl,Betadren,Dociton,Inderal,Obsidan,Obzidan,Propanolol,Propranolol Hydrochloride,Rexigen,AY 20694,AY20694,Hydrochloride, Propranolol
D011802 Quinidine An optical isomer of quinine, extracted from the bark of the CHINCHONA tree and similar plant species. This alkaloid dampens the excitability of cardiac and skeletal muscles by blocking sodium and potassium currents across cellular membranes. It prolongs cellular ACTION POTENTIALS, and decreases automaticity. Quinidine also blocks muscarinic and alpha-adrenergic neurotransmission. Adaquin,Apo-Quinidine,Chinidin,Quincardine,Quinidex,Quinidine Sulfate,Quinora,Apo Quinidine,Sulfate, Quinidine
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000889 Anti-Arrhythmia Agents Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. Anti-Arrhythmia Agent,Anti-Arrhythmia Drug,Anti-Arrhythmic,Antiarrhythmia Agent,Antiarrhythmia Drug,Antiarrhythmic Drug,Antifibrillatory Agent,Antifibrillatory Agents,Cardiac Depressant,Cardiac Depressants,Myocardial Depressant,Myocardial Depressants,Anti-Arrhythmia Drugs,Anti-Arrhythmics,Antiarrhythmia Agents,Antiarrhythmia Drugs,Antiarrhythmic Drugs,Agent, Anti-Arrhythmia,Agent, Antiarrhythmia,Agent, Antifibrillatory,Agents, Anti-Arrhythmia,Agents, Antiarrhythmia,Agents, Antifibrillatory,Anti Arrhythmia Agent,Anti Arrhythmia Agents,Anti Arrhythmia Drug,Anti Arrhythmia Drugs,Anti Arrhythmic,Anti Arrhythmics,Depressant, Cardiac,Depressant, Myocardial,Depressants, Cardiac,Depressants, Myocardial,Drug, Anti-Arrhythmia,Drug, Antiarrhythmia,Drug, Antiarrhythmic,Drugs, Anti-Arrhythmia,Drugs, Antiarrhythmia,Drugs, Antiarrhythmic
D001145 Arrhythmias, Cardiac Any disturbances of the normal rhythmic beating of the heart or MYOCARDIAL CONTRACTION. Cardiac arrhythmias can be classified by the abnormalities in HEART RATE, disorders of electrical impulse generation, or impulse conduction. Arrhythmia,Arrythmia,Cardiac Arrhythmia,Cardiac Arrhythmias,Cardiac Dysrhythmia,Arrhythmia, Cardiac,Dysrhythmia, Cardiac

Related Publications

G I Sidorenko, and A V Gurin, and M G Koliadko, and T L Iurkshtovich, and V L Nedorezov
Comparative antiarrhythmic activity of quinidine combined with propranolol and with sotalol.
January 1981, Archives internationales de pharmacodynamie et de therapie,
G I Sidorenko, and A V Gurin, and M G Koliadko, and T L Iurkshtovich, and V L Nedorezov
[Quinidine interactions with propranolol, phenytoin, verapamil and procainamide].
June 1984, Polski tygodnik lekarski (Warsaw, Poland : 1960),
G I Sidorenko, and A V Gurin, and M G Koliadko, and T L Iurkshtovich, and V L Nedorezov
The antiarrhythmic effects of verapamil and propranolol in aminophylline toxic dogs.
March 1983, Canadian Anaesthetists' Society journal,
G I Sidorenko, and A V Gurin, and M G Koliadko, and T L Iurkshtovich, and V L Nedorezov
[Comparative characteristics of the antiarrhythmic activity of lidocaine, trimecaine and pyromecaine].
January 1984, Sovetskaia meditsina,
G I Sidorenko, and A V Gurin, and M G Koliadko, and T L Iurkshtovich, and V L Nedorezov
The clinical pharmacology of antiarrhythmic drugs. Part II: Quinidine, propranolol, diphenylhydantoin, and bretylium.
January 1974, Cardio-vascular nursing,
G I Sidorenko, and A V Gurin, and M G Koliadko, and T L Iurkshtovich, and V L Nedorezov
A microelectrophysiological analysis of the pharmacodynamic basis for quinidine-propranolol antiarrhythmic potentiation.
December 1981, The Journal of pharmacology and experimental therapeutics,
G I Sidorenko, and A V Gurin, and M G Koliadko, and T L Iurkshtovich, and V L Nedorezov
Comparison of the antiarrhythmic activity of quinidine and quinine.
May 1977, Archives internationales de pharmacodynamie et de therapie,
G I Sidorenko, and A V Gurin, and M G Koliadko, and T L Iurkshtovich, and V L Nedorezov
The antiarrhythmic effects of quinidine and propranolol in the ouabain-intoxicated spinally transected cat.
February 1979, European journal of pharmacology,
G I Sidorenko, and A V Gurin, and M G Koliadko, and T L Iurkshtovich, and V L Nedorezov
A cardiac antiarrhythmic screening test in the rat: the effects of lidocaine, propranolol and quinidine.
January 1980, Archives internationales de pharmacodynamie et de therapie,
G I Sidorenko, and A V Gurin, and M G Koliadko, and T L Iurkshtovich, and V L Nedorezov
Propranolol and quinidine.
March 1972, The American journal of cardiology,
Copied contents to your clipboard!